Colocation Australia harnesses ADVA solution to offer low-cost, long-haul connectivity
ADVA (FSE: ADV) today announced that Colocation Australia (ColoAU), a subsidiary of 5G Networks Limited (ASX: 5GN), has deployed its FSP 3000 OpenFabric™ to give customers flexible and low-cost connectivity with complete freedom to adjust capacity as required. The company’s new national wavelength product uses bandwidth sourced from a range of providers to offer cost-effective long-distance transport. By using ADVA’s open OTN cross-connect technology, ColoAU is now able to optimize links between Australia’s mainland state capital cities and Singapore to offer the lower-speed services that businesses need. Customers can select data rates ranging from 1.25Gbit/s to 50Gbit/s over OTN, Ethernet, SDH/SONET and Fibre Channel interfaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200901005020/en/
ADVA is helping Colocation Australia optimize network capacity and give its customers the bandwidth they need (Photo: Business Wire)
“We’re using ADVA’s technology to solve one of the key problems that small and medium-sized companies face. They no longer need to waste valuable resources in overprovisioning links that end up redundant or obsolete and are able to support growing bandwidth requirements driven by demand. By utilizing the ADVA FSP 3000 OpenFabric™, we’re able to provide elastic bandwidth offerings that can instantly be turned up or down,” said Nic Tippelt, wholesale manager, ColoAU. “Our new national wavelength product lets customers take control. It empowers them to choose high-quality, secure, point-to-point connectivity that supports ever-changing capacity needs.”
The ADVA FSP 3000 OpenFabric™ gives ColoAU and 5GN Wholesale a truly scalable end-to-end architecture and the ability to support a wide range of client interfaces for metro, inter-capital or international connectivity. It enables the company to leverage other service provider and utility networks as its own and offer a unique combination of high capacity and flexibility. The ADVA FSP 3000 OpenFabric™ features open OTN switching technology, which extends the delivery of bandwidth services throughout the network and eliminates the boundaries of legacy OTN solutions. With the new service, ColoAU has become the first company to use the openness, flexibility and scalability of ADVA’s solution in this way.
“Our FSP 3000 OpenFabric™ creates an architecture that’s open, disaggregated and completely future-proof. It gives ColoAU’s customers the freedom to efficiently transport any mix of optical services, and scale as and when needed. By utilizing other networks to flexibly offer a wide range of wavelengths, the company is empowering enterprises across Australia to harness the ideal connectivity for their business needs,” commented Erik Lindberg, VP, sales, APAC, ADVA. “ColoAU’s new national wavelength product provides businesses across Australia and Singapore with an entirely new way to access the capacity they require. It enables them to seize new opportunities without major risk and eliminates wasted capacity and unnecessary cost.”
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.
About 5G Networks and Colocation Australia
Colocation Australia is a subsidiary company of 5G Networks. 5G Networks (ASX: 5GN) is a licenced telecommunications carrier operating across Australia. Our mission is to be Australia’s partner of choice for unifying a seamless digital experience for our customers across data connectivity, cloud and data centre services, underpinned by expert managed services in the business and wholesale markets. 5G Networks currently owns and operates its own nationwide highspeed data network with points of presence in all major Australian capital cities. www.5gnetworks.com.au.
ADVA Optical Networking SE, Munich, Germany
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mitsui Mining & Smelting Co., Ltd. to Initiate Mass Production of HRDP ® , a Special Glass Carrier for Next-Generation Semiconductor Packaging Devices25.1.2021 07:00:00 CET | Press release
For the commercialization of HRDP®1, a special glass carrier for the next-generation semiconductor packaging devices, Mitsui Mining & Smelting Co., Ltd. (President: Keiji Nishida; hereinafter, “Mitsui Kinzoku”) has been expanding the establishment of a system for mass production in collaboration with GEOMATEC Co., Ltd. (President: Kentaro Matsuzaki). Mitsui Kinzoku is pleased to announce today that mass production of HRDP® has started for a domestic multi-chip module manufacturer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210124005060/en/ Exterior photograph of HRDP®, in the 12-inch wafer type (Photo: Business Wire) In its January 2018 news release, Mitsui Kinzoku announced the development of HRDP®, a material for the creation of ultra-fine circuits using a glass carrier for the Fan Out panel level package, based on the RDL First method2. HRDP® is a special glass carrier capable of achieving high production efficiency o
Alaska Cargo and Cold Storage Launches Major Addition to the Global Cold Chain25.1.2021 06:01:00 CET | Press release
Alaska Cargo and Cold Storage, LLC (ACCS) and the State of Alaska executed a 55-year lease agreement at Ted Stevens Anchorage International Airport (ANC), marking a major milestone in the development of a more than 700,000-square-foot, climate-controlled warehouse facility. With 32.5 million cubic feet of capacity, the facility will provide ANC with a critical piece of infrastructure at the world’s sixth-busiest cargo airport. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210124005094/en/ Alaska Cargo and Cold Storage, LLC signed a 55-year ground lease with the State of Alaska for a 700,000-square-foot cold storage facility strategically located at Ted Stevens Anchorage International Airport, the sixth-busiest cargo airport in the world. (Photo: Ted Stevens Anchorage International Airport) “This project will improve shipping to and through Anchorage, create jobs, and show the world that Alaska is open for business,” said Al
Takeda Named Global Top Employer for Fourth Consecutive Year25.1.2021 01:00:00 CET | Press release
Takeda Pharmaceutical Company Limited(TSE:4502/NYSE:TAK) (“Takeda”) today announced that it is one of only 16 companies to achieve global Top Employer® certification for 2021. In addition to receiving the global certification for the fourth consecutive year, Takeda was also certified as a Top Employer in four regions and 38 countries. This underscores the company’s commitment to creating an exceptional people experience for its global workforce. For more than 30 years, Top Employers Institute has given annual award certification to companies with outstanding culture, work environments, benefits and opportunities for their people. The Institute certifies organizations based on the results of its HR Best Practices Survey. The survey covers 20 people-centric topic areas, including Career Development, Culture, Diversity & Inclusion, Learning, Sustainability, Values, Well-being and Work Environment. “We are very proud of the global, regional and country recognition we’ve received from Top E
GPD Companies, Inc. to Acquire Distrupol22.1.2021 14:33:00 CET | Press release
GPD Companies, Inc., an affiliate of One Rock Capital Partners, LLC (“One Rock”), today announced that it has entered into a definitive agreement to acquire Distrupol, a subsidiary of Univar Solutions Inc. (NYSE: UNVR) and a leading European distributor of thermoplastics to the polymer processing industry. Terms of the transaction, which is expected to close in the first half of 2021, were not disclosed. Headquartered in Surrey, England, with broad geographic reach across Europe, Distrupol has provided value-added sales and application development of thermoplastic resins for over 50 years. Through its decades-long relationships with world class supply partners, the company offers a robust array of superior performance products and solutions that meet the needs of diverse end users from leading and emerging industries, such as the consumer, medical, automotive, and electrical sectors, among others. Distrupol caters to over 1,300 customers across 13 countries with a portfolio of over 4,0
Schlumberger Announces Fourth-Quarter and Full-Year 2020 Results22.1.2021 12:50:00 CET | Press release
Schlumberger Limited (NYSE: SLB) today reported results for the fourth-quarter and full-year 2020. Fourth-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeDec. 31, 2020Sept. 30, 2020Dec. 31, 2019SequentialYear-on-yearRevenue $5,532 $5,258 $8,228 5% -33%Income (loss) before taxes - GAAP basis $471 $(54) $452 n/m 4%Net income (loss) - GAAP basis $374 $(82) $333 n/m 12%Diluted EPS (loss per share) - GAAP basis $0.27 $(0.06) $0.24 n/m 12% Adjusted EBITDA* $1,112 $1,018 $1,648 9% -33%Adjusted EBITDA margin* 20.1% 19.4% 20.0% 73 bps 6 bpsPretax segment operating income* $654 $575 $1,006 14% -35%Pretax segment operating margin* 11.8% 10.9% 12.2% 90 bps -40 bpsNet income, excluding charges & credits* $309 $228 $545 35% -43%Diluted EPS, excluding charges & credits* $0.22 $0.16 $0.39 37% -44% Revenue by Geography International $4,343 $4,210 $5,834 3% -26%North America 1,167 1,034 2,339 13% -50%Other 22 14 55 n/m n/m $5,532 $5,258 $8,228 5% -33% *These are non-
JEOL: Release of a New Cold Field Emission Cryo-Electron Microscope CRYO ARM™ 300 II (JEM-3300)22.1.2021 07:00:00 CET | Press release
JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) announces the release of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM™ 300 II (JEM-3300), to be released in January 2021. This new cryo-EM has been developed based on the concept of "Quick and easy to operate and get high-contrast and high-resolution images". This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005316/en/ Cold Field Emission Cryo-Electron Microscope CRYO ARM(TM) 300 II (JEM-3300) (Photo: Business Wire) Development Background Recent dramatic improvement of resolution in single particle analysis (SPA) using cryo-EM has led to SPA as an essential method for structural analysis of proteins. To address this market, JEOL released the CRYO ARM™ 300 in 2017. Equipped with a cold field emission gun (Cold FEG) for enhanced resolution and a cryo-stage for loading multiple samples, the CRYO ARM™ 300 has continued to achieve best-in-class res
ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment21.1.2021 23:12:00 CET | Press release
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Cabenuva, the first and only complete long-acting regimen for the treatment of HIV-1 infection in adults. Cabenuva is provided as a co-pack with two injectable medicines — ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine— dosed once monthly, as an option to replace the current antiretroviral (ARV) regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per milliliter [mL]) on a stable regimen, with no history of treatment failure, and with no known or suspected resistance to either cabotegravir or rilpivirine. Prior to initiating treatment of Cabenuva, oral dosing of cabotegravir and rilpivirine should be administered for approximately one month to assess the tolerability of each therapy.1 Lynn Baxter, Head of North America, ViiV He
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom